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Abstract
Ménière’s disease (MD) is a clinical syndrome characterized by recurrent episodes of spontaneous vertigo, unilateral fluctuat-
ing sensorineural hearing loss, tinnitus, and aural fullness. Endolymphatic hydrops is recognized as the pathophysiological 
substrate of the disease, having been demonstrated in anatomical pathological studies and more recently by magnetic reso-
nance imaging (MRI). The current criteria of the disease, however, remain symptom based and do not include the demon-
stration of endolymphatic hydrops. The authors review MRI techniques and diagnostic criteria of endolymphatic hydrops 
and the role of MRI in MD is discussed.
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Introduction—current issue
MD is a chronic disease with a prevalence of 200–500 per 
100,000 individuals [1], characterized by a recurrent clini-
cal syndrome of audiovestibular symptoms, namely, spon-
taneous vertigo, unilateral hearing loss, aural fullness, and 
tinnitus.
In 1861, Prosper Ménière was the first to recognize the 
inner ear at the origin of the symptoms with endolym-
phatic hydrops only later, in 1937, being described by Brit-
ish [2] and Japanese [3] researchers. Nowadays, its cause 
remains undetermined, but the pathophysiological substrate 
is known: the increase in the endolymphatic space of the 
membranous labyrinth, partially occupying the usual space 
of the perilymph (Fig. 1).
Although imaging evolution currently allows the iden-
tification and quantification of endolymphatic hydrops, the 
diagnostic criteria remain clinical and based on symptoms 
and hearing evaluation only, and do not consider the ves-
tibular evaluation or the demonstration of endolymphatic 
hydrops.
Clinical diagnostic criteria of MD
The clinical criteria for diagnosing MD have undergone 
some evolution over time, although they have maintained 
a classification based on symptoms, which are often diffi-
cult to target. In 1967, Hinchcliffe [4] described the classic 
clinical picture, with a triad of spontaneous vertigo, hear-
ing loss, and aural fullness/tinnitus, after excluding other 
causes (pathology of the middle ear, central nervous system, 
pharmacology, systemic diseases, among others); later on, 
some light forms of the disease were described, in which the 
clinical picture is not complete [5].
In 1972, the American Academy of Otolaryngology 
and Head and Neck Surgery adopted the nomenclature of 
“vestibular MD” and “cochlear MD” [6], abandoning it 
repeatedly in 1985 [7] and in 1995 [8], alleging insufficient 
evidence that these monosymptomatic conditions have a 
common pathophysiology to MD.
The criteria revised in 1995 classify MD as “possible 
MD”—episodic vertigo or fluctuating deafness, “prob-
able MD”—a 20-min rotating vertigo episode accompa-
nied by tinnitus and documented sensorineural hearing 
 * Rita Sousa 
 ritafsousa1@gmail.com
1 Neuroradiology Department, Centro Hospitalar Universitário 
Lisboa Norte, Rua Casal da Raposa, 46, Caselas, 
1400-050 Lisbon, Portugal
2 Otorhinolaryngology Department, Centro Hospitalar 
Universitário Lisboa Norte, Lisbon, Portugal
3 Imagiology Department, Lisbon Red Cross Hospital, Lisbon, 
Portugal
4 Institute of Molecular Medicine, Lisbon, Portugal
 Neuroradiology
1 3
loss, “definite MD”—two or more episodes of vertigo of 
20 or more minutes in duration, accompanied by tinnitus 
and documented sensorineural hearing loss, and “certain 
MD”—criteria for definitive MD and additional histologi-
cal, usually post-mortem, demonstration of hydrops in the 
affected ear. This classification continues to include the 
diagnosis of MD in patients whose installation of the com-
plete clinical picture is more indolent (20% may take up 
to 5 years and 10% more than 10 years to present the full 
clinical picture) [9].
In 2015, the diagnostic MD criteria were reclassified 
by Barany Society [10] (Table 1) as “definite MD” and 
“probable MD,” but here removing the “certain MD” that 
included the anatomopathological demonstration endo-
lymphatic hydrops. According to the 2015 consensus, 
the “definite MD”consists of two or more episodes with 
20 min to 12 h of vertigo associated with unilateral sen-
sorineural hypoacusia for low to medium frequencies and 
fluctuating aural symptoms, such as tinnitus and ear full-
ness with “probable MD” not including the audiometric 
demonstration for hearing loss.
This classification has been contested mainly because it 
excludes endolymphatic hydrops demonstration from the cri-
teria, especially at a time when it is possible to demonstrate 
it in vivo, by MRI. In 2016, Nakashima [11] argued that all 
patients with clinical suspicion of MD should be studied 
with MRI of the inner ear, proposing a new classification of 
MD including MRI of endolymphatic hydrops. Bearing in 
mind that the installation of the “complete” clinical picture 
may take more than 10 years in many cases [9], the authors 
[11] propose that monosymptomatic patients with endolym-
phatic hydrops should be treated as having MD, as suggested 
by the 1972 classification, in which MD subtypes were rec-
ognized without the complete clinical picture (“vestibular 
MD” and “cochlear MD”).
Based on the diversity of clinical presentations and 
with an emphasis on the importance of hydrops diagnosis, 
Gurkov goes further and demands not only new diagnostic 
criteria (including endolymphatic hydrops) [12] but also a 
new stratification [13], in patients “with hydrops” (where 
MD would be included) and patients “without hydrops,” 
as a way to select those who would benefit from therapy 
Fig. 1  Schematic representation of the membranous labyrinth with 
normal sized endolymphatic space on the left (healthy ear) and 
enlarged endolymphatic space on the right (MD). Endolymphatic 
space is represented in red and perilymphatic space is black. Utricle 
(u) is in close anatomic relation with semicircular canals (lateral, 
lscc; superior, sscc; posterior, pscc). Saccule (s) is located in ante-
rior, inferior, and medial part of vestibule (V) (pars inferior) in ana-
tomic proximity to cochlea (C). In endolymphatic hydrops (right), the 
endolymphatic spaces enlarge (red); utricle and saccule are enlarged, 
partly obliterating perilymphatic space and herniating into the ampul-
lary (★) and non ampullary ends of semicircular canals
Table 1  Barany Society 
diagnostic criteria of MD 
proposed in 2015 [10]
Definite MD • At least two episodes of spontaneous vertigo that last 20 min to 12 h
• Audiometric documented low to medium frequency neurosensorial hearing loss in 
the affected ear, before, during, or after the vertigo episode
• Cochlear fluctuating symptoms (hearing, aural fullness, tinnitus) in the affected ear
• No other diagnosis of vestibular pathology
Probable MD • At least two episodes of vertigo or dizziness each lasting 20 min to 24 h
• Cochlear fluctuating symptoms (hearing, aural fullness, tinnitus) in the affected ear
• No other diagnosis of vestibular pathology
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directed at hydrops in the evolution of the natural history of 
the disease. In fact, it seems endolymphatic hydrops is not 
exclusive of typical MD, and it can be found in atypical MD 
presentations (such as monosymptomatic cases) and in other 
conditions, such as malformations, intra labyrinthine tumors, 
and endolymphatic sac tumors [14].
Anatomopathological evidence 
of endolymphatic hydrops in MD
Endolymphatic hydrops is the most original finding in MD 
(Fig. 1) and has always been considered in discussions of 
the disease. In 2013, Foster et al. [15] reviewed all pub-
lished anatomopathological studies of temporal bones that 
included 165 patients with clinical suspicion of MD accord-
ing to 1995 [8] clinical criteria, having found endolymphatic 
hydrops in all 163 of the cases of definitive MD in at least 
one ear (98.8%). It was not possible to know whether the two 
cases without endolymphatic hydrops would have developed 
criteria for definite DM due to the lack of clinical records. 
The authors concluded that endolymphatic hydrops is more 
than an epiphenomenon, since there is a practically perfect 
association between each case of definitive MD and the 
occurrence of endolymphatic hydrops. They theorize that 
endolymphatic hydrops probably will not be enough to cause 
the complete clinical picture, but associated with one or 
more additional (unknown) cofactors, asymptomatic endo-
lymphatic hydrops may be converted into symptomatic MD.
MRI of endolymphatic hydrops in humans
Until recently, the demonstration of endolymphatic hydrops 
was not likely to be included in the criteria for diagnos-
ing the disease in vivo, since its demonstration was limited 
to anatomopathology [16], so the diagnostic criteria were 
mainly clinical. In this era, the role of MRI was limited to 
excluding other causes for the clinical picture, such as cere-
brospinal fluid hypotension, cerebrovascular disease, inflam-
matory conditions (such as multiple sclerosis), arteriovenous 
malformations, posterior fossa occupying space lesions, 
and inner ear pathology (malformative, inflammatory and 
tumor). Computed tomography allowed, in a complementary 
way to MRI, the detailed evaluation of the middle ear and 
the bony labyrinth, allowing the identification of inflamma-
tory pathology, otosclerosis, as well as some findings that 
are believed to be associated with MD, namely, stenosis of 
the vestibular aqueduct, high riding jugular bulb, and dehis-
cences of the semicircular canals [17].
In 2005, Zou et al. [18] managed to separate the endo 
and perilymphatic compartments by MRI in animal and 
human models, and 2  years later, the Japanese group 
published on the demonstration of endolymphatic hydrops 
by MRI in humans [19, 20] through specific algorithms 
with FLAIR (Fluid Attenuation Inversion Recovery) 
sequences. The latter, more sensitive in the identifica-
tion of contrast in the perilymph, when compared to the 
T1 sequence, permits visualizing very small amounts of 
contrast in the inner ear. This was a crucial milestone, 
since it allows diagnosing endolymphatic hydrops in vivo, 
corroborating the clinical diagnosis in MD patients. The 
basis of the technique explores the different penetration 
capabilities of the contrast agent in the endo and perilym-
phatic spaces, obtaining a higher signal in the perilymph, 
which can thus be distinguished from the endolymph. 
Later, the same group managed to improve the contrast 
between the endolymph (without contrast) and the bone, 
through the turbo-spin echo 3D inversion-recovery tech-
nique (3D-Real-IR) [21]. This allowed to better diagnosing 
endolymphatic hydrops in definitive MD and in mono-
symptomatic cases, as well as to assess their evolution over 
the course of the disease [22]. Endolymphatic hydrops is 
present in all patients with definitive MD [23, 24], as it 
has been demonstrated with the anatomopathological stud-
ies previously mentioned. Also, it is now known that the 
type of symptoms present is related to the different loca-
tions (utricle, saccule, cochlea) preferentially affected by 
hydrops [9], although there is no direct and simple rela-
tionship between clinical manifestations and the degree 
and topography of the hydrops for each individual, with 
some patients showing marked endolymphatic hydrops 
with relatively preserved auditory function. On the other 
hand, it is also possible not only to identify endolymphatic 
hydrops in the ears that are still asymptomatic [9] but also 
to identify bilateral hydrops in more advanced clinical 
stages of the disease [25].
The literature on MRI for the diagnosis of endolym-
phatic hydrops in MD is still globally scarce and dif-
ficult to dissect due to the great variability in patient 
selection (subjective clinical criteria), the absence of 
healthy control groups (it is difficult to obtain healthy 
controls, due to ethical concerns due to the need to inject 
contrast with some studies establishing the “asympto-
matic” ear as the control, problematic approach due to 
the usual bilateral nature of this condition), the vari-
ability of the used MR techniques (difficult to repro-
duce in different devices), the analysis of the images 
obtained (qualitative, semi-quantitative and quantitative; 
pre- or post-processed images), the different scales for 
presenting the results (use of different cut-off values 
for endolymphatic hydrops and use of different measure 
methods, for example, including or not the ampulla of 
semicircular canals), and the lack of longitudinal studies 
necessary to clarify the benefit of MRI in the diagnosis 
and follow-up of these patients.
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Intratympanic and intravenous gadolinium 
administration techniques
In 2007, Nakashima et al. [19] published the first in vivo 
demonstration of endolymphatic hydrops in MD, after 
intratympanic contrast injection. For this technique, a 
diluted gadolinium suspension (0.3–0.6 ml with 1:8 dilu-
tion) is injected through the tympanic membrane under 
microscopic control. This contrast is absorbed mainly 
through the oval and round window membranes to the per-
ilymphatic space of that ear, not diffusing to the endolym-
phatic space due to the presence of tight junctions (Fig. 2). 
After 24 h, MRI images are acquired in a high magnetic 
field device (3 T) with the T2 3D FLAIR sequence, show-
ing the hyperintense perilymphatic space, which contrasts 
with the hypointense endolymphatic space (Fig. 2).
When compared with the intravenous technique, this 
method allows higher concentrations of contrast in the 
perilymph, making the interpretation of the images easier. 
Nevertheless, the asymmetry in the distribution of the 
contrast may occur for reasons unrelated to the perilym-
phatic volume, such as different contrast permeability of 
the oval and round windows. Also, due to the contrast 
distribution pattern, it has greater expression in the coch-
lear basal loop. Overall, it is a more invasive technique, 
but with a lower risk of systemic toxicity, although local 
toxicity has rarely been described [26]. Several publi-
cations demonstrated the safety of the intratympanic 
use of gadolinium in diluted solutions [27–29] but the 
intratympanic use of gadolinium is still an off label use 
of gadolinium, contrary to the intravenous route of admin-
istration. Importantly, the evaluation of the two ears is 
independent. As some patients are reluctant to intratym-
panic injection of the “asymptomatic” ear, some authors 
combine the intratympanic (on the symptomatic side) and 
intravenous (to assess the “asymptomatic” ear) techniques 
[30].
In 2010, Naganawa [31] described the intrave-
nous technique of visualizing the endolymphatic 
and perilymphatic spaces by MRI through the intra-
venous administration of a simple dose of gadolin-
ium (0.1–0.2 ml/kg). Less invasive and with a more 
homogeneous contrast distribution, this allows for 
the evaluation of changes in the permeability of the 
blood-perilymphatic barrier, unable to assess with the 
intratympanic technique. This technique also requires a 
shorter 4-h interval between intravenous administration 
of contrast and image acquisition (Fig. 2).
Several publications used these techniques (intravenous, 
intratympanic or combined), with variable contrast doses 
and different technical parameters, such as the number of 
receptor channels of the skull antenna. Both techniques 
(intra-tympanic and intravenous) with its advantages and 
Fig. 2  Schematic representation of the endolymphatic and perilym-
phatic spaces by magnetic resonance. Left image—in the “conven-
tional” T2 3D sequence, the contents of the membranous labyrinth 
(perilymphatic and endolymphatic spaces) are both hyperintense. 
Right image—when contrast (intravenous or intratympanic) is 
administered, it will reach the perilymphatic space (with elevation 
of the signal) but does not pass into the endolymphatic space; thus, 
the endolymphatic space presents suppression of the signal in 3D 
FLAIR (becoming hypointense) while the perilymphatic space is not 
suppressed in this sequence (hyperintense). It is difficult to establish 




disadvantages show consistent correlations between the 
degree of hydrops and the result of audiovestibular tests 
(audiometry, electrocochleography and caloric tests), espe-
cially with pure tone audiometry [32].
A recent paper from Gurkov [33] focused on the “index 
ear” concept. It is defined as the more symptomatic ear 
based on patient history, low frequency audiometric data, 
and caloric testing. He finds a strong correlation between 
the more symptomatic side and the more hydropic side, and 
highlights that unilateral imaging (intratympanic technique 
with higher imaging quality) might be sufficient in most 
patients for the diagnosis of endolymphatic hydrops.
In 2017, MR techniques without contrast administration 
were described [34] with T2 3D images (FIESTA, CISS, 
DRIVE), allowing for the measurement of the diameter of 
the saccule. The limitations in cochlear evaluation and the 
reliability of the small structures measurements were a mat-
ter of debate among some authors [35].
MRI sequence parameters 
and post‑processing
The emergence of the intravenous gadolinium technique has 
added information regarding the permeability of the blood-
perilymphatic barrier, but with the disadvantage of lower 
gadolinium concentrations in the perilymph. This motivated 
the development of techniques for detecting the faintest 
signs of contrast in the perilymph [36, 37] by adjusting the 
inversion time between the null point of the perilymph with 
gadolinium and the endolymph without gadolinium. This 
technique uses subtraction of images with different inver-
sion times, allowing a good visualization of the endolym-
phatic, perilymphatic, and bone spaces in a single image 
(Fig. 3). This process is called HYDROPS (HYbriD of 
Reversed image Of Positive endolymph signal and native 
image of positive perilymph Signal) (subtraction between 
PPI (positive perilymph) and PEI (positive endolymph) [36]. 
HYDROPS2 is reconstructed by subtracting the cisternoMR 
(usually T2 3D turbo spin echo with variable flip angle).
The acquisition times were, however, initially long (ini-
tially over 30 min), which limited its routine application. 
They then developed the HYDROPS2-Mi2 method (HYbrid 
of Reversed image Of MR cisternography and a positive 
Perilymph Signal by heavily T2-weighted 3D-FLAIR-
Multiplied by T2), reducing the acquisition time by two-
thirds [38]. This represents HYDROPS and HYDROPS2 
multiplied by the cisternoMR image in order to increase 
the signal-to-noise ratio (obtaining HYDROPS-Mi2 and 
HYDROPS2-Mi2 respectively).
Some authors defend the use of T2 3D FLAIR maximum 
intensity projection reconstruction (MIP) images (compar-
ing to two-dimensional evaluations) for the evaluation of 
endolymphatic hydrops [39].
Indicative parameters of the T2 FLAIR sequence are 
widely available in literature [31, 40], but have to be opti-
mized for each device and images should be obtained in 
asymptomatic control groups. An input from an MRI 
Fig. 3  Schematic representation of the HYDROPS (hybrid of the 
reversed image of the positive endolymph signal and native image 
of the positive perilymph signal) image—the technique uses the sub-
traction of images with different inversion times, namely from the T2 
3D IR image (PEI positive endolymphatic image) to the 3D flair (PPI 
positive perilymphatic image), improving the interface between the 3 
spaces in a single image: endolymphatic (hypointense), perilymphatic 
(hyperintense), and bone (neutral)
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physicist is ideal, although not always feasible. The sequence 
parameters such as the echo time (TE) as great impact on 
the degree of enhancement [31] and variations in the inver-
sion time (TI) may influence the apparent size of endolym-
phatic structures [41]. Increased signal from enhancing peri-
lymph can be obtained with a constant flip angle. Isotropic 
sequences should be used given the need to evaluate multi-
ple planes [42], but a better definition of cochlear hydrops 
implicates improving in-plane resolution at expense of iso-
tropic imaging (avoiding EH being repeated). A voxel size 
of 0.7 mm contributes to an adequate signal to noise ratio 
[40]. The endolymphatic hydrops sequence should be per-
formed 3.5 to 4.5 h after intravenous gadolinium injection 
[43]. Some centers use double dose of intravenous contrast 
(0.2 mm/kg body weight) [40] but single dose is feasible 
by using more heavily T2-weighted FLAIR sequences [31].
In addition to endolymphatic hydrops imaging, it is 
necessary to exclude other differential diagnosis that can 
present with audiovestibular symptoms (Table 3). For 
this reason, we usually use axial T2 Flair and diffusion 
imaging of the brain (to exclude intra axial lesion) and 
high resolution T1-weighted imaging (pre- and post-
gadolinium) and T2-3D weighted imaging of the inner 
ear/cerebellar pontine angle (to exclude space occupying 
lesions and evaluate the signal and morphology of inner 
ears structures).
MRI antenna and image quality
Though first reports of in vivo endolymphatic hydrops have 
been made at 3 T MRI [19], and grading endolymphatic sys-
tems have been developed from 3 T MRI (Figs. 4 and 5) it is 
also possible to obtain reliable information from 1.5 T MRI. 
Endolymphatic hydrops was demonstrated in humans for the 
time on a 1.5 T MRI in 2012 [44]. Using phase sensitive 
inversion recovery MRI following intratympanic adminis-
tration of gadolinium and multiple TI values, the authors 
obtained confident identification of endolymphatic hydrops 
in Meniere’s patients even when perilymph opacification 
was suboptimal at one TI value. One year after, Naganawa 
demonstrated endolymphatic hydrops in Ménière’s disease 
using intravenous administration of single dose of gad in 
1.5 T scanner and a 32-channel head coil [45], optimizing 
the protocol with enlargement of pixel size to compensate 
the decrease in signal-to-noise ratio. Recently, Gurkov 
[46] introduced a 1.5 T high-resolution MRI protocol with 
intratympanic technique that bypasses the need for 3 T scan-
ners and permits endolymphatic hydrops imaging across dif-
ferent health care systems around the world. He proposes a 
two slice system for grading vestibular hydrops.
As the inner ear is an anatomical structure with a region 
of interest of small dimensions and low signal, factors 
such as sensitivity and pixel resolution to obtain images 
with clinical utility become critical in magnetic resonance. 
Recently, Zou et al. [47] reviewed MRI studies using dif-
ferent MR coil. Regardless of the 3 T magnetic resonance 
model and the sequences used, coils with a greater num-
ber of elements produce images with better spatial resolu-
tion. However, in 3 T, is it possible to obtain fair images 
of endolymphatic inner ear spaces with lower number of 
elements—images from Figs. 6, 7, 8, 9, 10, 11, 12 and 13 
were obtained from a 8-channel head coil from Philips 
Achieva 3 Tesla MRI scanner, using intravenous single 
dose of gadolinium and a delayed acquisition 4 h after 
contrast injection.
The sensitivity of magnetic resonance is dependent 
on the type of radio frequency coil used to receive the 
signal. With the simultaneous acquisition and the obtain-
ing of combined data from several receivers positioned 
Fig. 4  Schematic representation of the cochlear membranous laby-
rinth in the axial plane along the greater axis of modiolus (m), 
according to Nakashima, Barath and Bernaerts. A—Grade 0 cochlear 
membranous labyrinth. Bony spiral lamina (grey arrow), scala ves-
tibuli (sv), scala tympani (st), and small scala media (black arrow). 
B—Grade 1 cochlear endolymphatic hydrops with scala media 
enlargement (black arrow) and partial obliteration of scala vestibuli. 
C—Grade 2 cochlear endolymphatic hydrops with total obliteration 
of scala vestibuli by enlarged endolymphatic space (solid arrow)
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in proximity to the area to be studied, it is possible to 
improve the signal-to-noise ratio and the resolution of 
small surface coils without significantly increasing the 
acquisition time [48]. It is accepted that the greater the 
number of elements used, the greater the signal-to-noise 
ratio and the spatial resolution in the area close to the 
elements of the antenna (for example an antenna with 96 
receiver channels proved to be superior to an antenna of 32 
channels in terms of signal-to-noise ratio) [49]. However, 
a larger number of channels generate a huge influx of data 
Fig. 5  Schematic representation of the vestibular membranous lab-
yrinth in the axial plane, A to D according Nakashima [47] (A, C, 
D), Barath [51] (A, C, D), Bernaerts (A, B, C, D) [49], adding a 
fourth degree (E) from Gurkov [16]. A—Grade 0 (normal) vestibular 
membranous labyrinth. Small sacule (black arrow) and utricle (grey 
arrow), usualy visible at pars inferior. B—Grade 1 (mild) vestibular 
endolymphatic hydrops with sacule enlargement (black arrow) but 
still separated from the utricle (grey arrow). C—Grade 2 (moderate) 
endolymphatic hydrops with confluence of utricle and sacule (black 
arrow) and partial obliteration of perilymphatic space (grey arrows). 
D—Grade 3 (severe) vestibular endolymphatic hydrops with marked 
enlargement of the confluent endolymphatic space (black arrow) and 
total obliteration of perilymphatic space of the vestibule. E—Grade 4 
(extreme) vestibular endolymphatic hydrops with herniation into the 
ampullae of lateral semicircular canal (black arrow)
Fig. 6  Patient with a single 
episode of spontaneous vertigo 
for 2 years and bilateral low 
frequency neurosensorial earing 
loss, more severe on the left. a 
and b Axial T2 3D images of 
the right (a) and left (b) ears: 
it is possible to evaluate the 
morphology and dimensions of 
the total membranous labyrinth 
(vestibules—white arrows—
and cochleas). c and d Axial 
HYDROPS images of the right 
(c) and left (d) ears obtained 
4 h after intravenous gado-
linium injection: endolymphatic 
space is enlarged in the left ear 
(d)—increase in scala media of 
apical (black arrow) and middle 
turn (grey arrow) of cochlea, 
completely obliterating the 
scala vestibuli space (cochlear 
hydrops grade 2); sacule and 
utricle confluence (white arrow) 
completely effacing perilym-
phatic space (vestibular hydrops 
grade 3); in the right ear (c), the 
endolymphatic space is reduced 
(normal in size) in apical turn 
(black arrow) and middle turns 
(grey arrow) of cochlea; sacule 
(solid white arrow) is smaller 




and an overload on the image reconstruction computer, 
significantly increasing the reconstruction times. In the 
experience of Zou et al. [47], the best image quality of the 
inner ear is obtained with a combination of a 16-channel 
skull antenna and a 7 cm ear surface antenna. Small anten-
nas have better spatial resolution and these surface coils 
are much closer to the ear than head coils; having a larger 
diameter allows obtaining signal from deeper structures, 
Fig. 7  Patient with clinical diagnosis of definite MD (recurrent spon-
taneous vertigo and left neurosensorial earing loss with 2  years of 
duration). Axial HYDROPS image showing non confluent enlarge-
ment of sacule (solid black arrow) and an utricle with normal size 
(dashed black arrow); perilymphatic space patent (white arrows)—
grade 1 endolymphatic hydrops according Bernaerts [49] (corre-
sponding to B on Fig. 6), SURI > 1 [40]
Fig. 8  Patient with diagnosis of definite MD (six years of duration of 
spontaneous recurrent vertigo and right neurosensorial earing loss). 
Axial MR HYDROPS images of right ear according lateral semicir-
cular canal plane. Confluent enlargement of vestibular endolymphatic 
space (white arrow) incompletely effacing the perilymphatic space of 
the vestibule (black arrows)—grade 2 endolymphatic hydrops (Bern-
aerts)
Fig. 9  Patient with recent diagnosis of definite MD (1 year duration 
of spontaneous recurrent vertigo and neurosensorial hearing loss) in 
the right ear. Axial MR images of right ear with HYDROPS showing 
vestibular endolymphatic hydrops completely obliterating the peri-
lymphatic space of the vestibule with herniation into the ampullary 
region (white arrow)
Fig. 10  Axial MR HYDROPS image of the left cochlea from a 
patient with fluctuating left earing loss and low frequency neurosen-
sorial hypoacusia on audiogram. Grade 2 cochlear endolymphatic 
hydrops with complete effacement of the scala vestibuli (solid white 




such as the inner ear, with a better signal-to-noise ratio 
than head antennas.
Diagnostic imaging criteria
Similar to the imaging technique, the imaging classifica-
tion has also undergone several updates. The first semi-
quantitative scale of endolymphatic hydrops was developed 
in Nagoya in 2008 and published by Nakashima in 2009 
[50], subdividing the cochlear and vestibular evaluation 
(since the volumes of the endolymphatic space in the ves-
tibule and cochlea differ significantly in healthy subjects) 
(Table 2, Figs. 4 and 5). In the cochlea, this classification 
is based on the displacement of the Reissner membrane and 
on the proportional difference between the cochlear duct 
and the vestibular scala (grades 0 to 2) (Figs. 4, 6 and 10). 
In the vestibule, it consists on the ratio between the area of 
the endolymphatic space and the total area of the membra-
nous vestibule (grades 0 to 2) when assessed in the axial 
plane. In Fig. 6(c), normal-sized endolymphatic spaces are 
seen—at the lower level of the vestibule, the saccule is usu-
ally a smaller round structure located anterior and medially; 
the utricle is larger than saccule and horizontally oriented 
in healthy ears and it is located at the most superior and 
posterior part of the vestibule (Fig. 1). According to this 
scale, several studies have found mild vestibular hydrops in 
94–100% of symptomatic ears in MD [42, 51–53], although 
it was also found in 53–100% of asymptomatic ears [51–53], 
in 66% of other otological conditions [49], and in 90% of 
healthy volunteers [42]. It is therefore assumed that this cut-
off value has low specificity but high sensitivity and can 
therefore be useful as an exclusion factor in MD when the 
clinical diagnosis is uncertain. 
However, the cut-off value for hydrops varies between 
authors and Barath et al. [54] considers 50% the cut-off value 
for vestibular hydrops grade 1 (Figs. 5C and 8), with grade 
2 (Figs. 5D and 6d) being the maximum vestibular hydrops 
with practically total obliteration of the perilymphatic space. 
In order to avoid overdiagnosis of vestibular hydrops, Bar-
ath based on data from 20 asymptomatic individuals [55] in 
which the endolymphatic space could reach 41% of the total 
membranous labyrinth. Applying this scale, Barath misses 
endolymphatic hydrops in 10% of MD cases.
Gurkov introduces a 4-degree scale for evaluating endo-
lymphatic hydrops to the original Nakashima scale by MRI 
(higher grade corresponding to extreme hydrops), correlat-
ing them for the first time with the audiovestibular function 
[56] (Figs. 5E, 9, 11, 12 and 13). This fourth stage cor-
responds to herniation of vestibular endolymphatic spaces 
anteriorly into de ampulla of lateral semicircular canal 
(Figs. 8 and 11), or posteriorly (utricle) into the (non amp-
ullary) limb of lateral semicircular canal (Figs. 11 and 13).
In 2017, Attyè [42] reported an inversion of the saccule 
and utricle ratio (SURI) as the initial marker of the disease 
(SURI > 1 in 15/30 patients with MD disease and in none of 
the 30 healthy controls) (Figs. 5B and 7).
In 2019, new imaging criteria were proposed by the Ant-
werp group [57]—modified scale with 4 degrees (Figs. 4 and 
5A–D ). The cochlear evaluation (Fig. 4) remains unchanged 
in relation to the Barath’s criteria (Fig. 4) and a degree is 
added to the vestibular evaluation (Fig. 5B ): degree 0—utri-
cle and saccule occupying less than 50% of the total area of 
the membranous vestibule (Figs. 5A and 6C); grade 1—sac-
cule equal to or greater than the utricle, but not confluent 
(Figs. 5B and 7); grade 2—confluent utricle and saccule, 
partially obliterating the perilymphatic space, with a rim 
of surrounding contrast enhancement left (Figs. 5C and 8); 
grade 3—maximum dilation of the utricle and saccule, con-
fluent, with total obliteration of the perilymphatic space 
(Figs. 5D and 6D), and incipient herniation of the utricle to 
the non-ampullary aspect of the lateral semicircular canal 
(Figs. 11 and 13). In the same study, they also assessed the 
intensity of the gadolinium signal in the perilymphatic space 
as a measure of disruption of the hemato-perilymphatic bar-
rier in the cochlea and vestibule in a semi-quantitative way, 
concluding that a higher signal intensity in the cochlear peri-
lymphatic space is a very specific sign to the disease, and 
Fig. 11  Axial HYDROPS (above) and delayed 3D FLAIR after intra-
venous gadolinium injection (below) from a patient with definite 
right MD diagnosis. Grade 2 cochlear (solid white arrow) and grade 
4 vestibular (dashed white arrow) hydrops is seen on the right ear; 
note utricle herniation into posterior limb of lateral semicircular canal 
(dashed white arrow). Asymmetric gadolinium enhancement is seen 
in perilymphatic space of basal turn of cochlea, pronounced on the 
right (white arrowhead), subtle on the left (grey arrowhead)
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therefore proposing a new evaluation algorithm, which starts 
with the signal intensity in the cochlear perilymphatic space 
(Fig. 11) and secondarily uses the 4-degree evaluation of the 
vestibule. This combined approach resulted in an improved 
diagnostic accuracy compared to previous grading systems. 
This important paper is retrospective, without an asympto-
matic control group.
These relevant findings were corroborated in a recent 
paper from Steekelenburg [58]. In this study, the authors 
evaluated 220 patients with MR T2 3D and 3D FLAIR 4 h 
after intravenous gadolinium injection. These patients were 
retrospectively evaluated in terms of clinical characteristics 
and the evaluated ears were separated in 4 groups: definite 
MD, probable MD, other vertigo-associated inner ear pathol-
ogy not attributable to MD, and asymptomatic (contralateral 
MD ears). The images were scored for hydrops (Barath’s 
scale and additional inversion saccule/utricle size) and visual 
signal intensity of the basal turn of the cochlea. Besides 
the retrospective design, the study hampers the potential to 
correlate imaging and clinical findings. It clearly points to 
an increased positive predictive value of the combination of 
endolymphatic hydrops and perilymphatic enhancement in 
Fig. 12  Initial MRI (left images) and 2-year follow-up MRI (right 
images). Axial HYDROPS (above) and delayed T2 3D FLAIR 4  h 
after intravenous gadolinium injection (below) at midmodiolar level. 
Patient presents with low frequency bilateral neurosensorial earing 
loss (more severe on the right), spontaneous vertigo attacks lasting 
5–10  min and fluctuating bilateral aural fullness, initially classified 
as atypical MD (cochlear MD)—MRI (left images) shows grade 2 
bilateral cochlear hydrops (solid black arrows) and bilateral ves-
tibular hydrops, grade 4 on the right and grade 2 on the left (solid 
white arrows); a rim of perilymphatic space is still patent in left ear 
(black arrowhead). Marked asymmetry of gadolinium enhancement in 
perilymphatic space of the cochlea (apical, middle, and basal turns), 
pronounced on the right,, subtle on the left (white arrowheads). In 
2  years (right images), the patient experienced progressive clinical 
worsening (increased in number of vertigo attacks, more than 30 min 
each, and worsening of earing loss, mainly on the left side), now ful-
filling clinical criteria for definite MD. The right ear remains stable 
in follow-up MRI (grade 4 vestibular hydrops—dashed white arrow, 
grade 2 cochlear hydrops—back dashed arrow, and marked perilym-
phatic enhancement white arrowhead). The left ear shows clear clini-
cal and imaging progression with vestibular hydrops changing from 
grade 2 to grade 4 (no perilymphatic space visible in left vestibule—
dashed white arrow, persistent grade 2 cochlear hydrops—dashed 
black arrow, and marked increase of perilymphatic enhancement in 
cochlea (now symmetric)—white arrowhead
Fig. 13  Initial (left image) and 3-year follow-up (right image) axial 
HYDROPS images from a patient with diagnosis of left definite MD. 
On initial MRI vestibular, endolymphatic space is enlarged (solid 
white arrow), with confluence of utricle and saccule; perilymphatic 
space is partially effaced but a rim of perilymphatic space remains 
visible (black arrowheads). On follow-up MRI, an increase of ves-
tibular endolymphatic space is seen, obliterating perilymphatic space, 
with herniation of utricle into posterior limb of lateral semicircular 
canal (dashed white arrow). Grade 2 cochlear hydrops remains stable
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the diagnosis of definite MD in patients with suspected MD. 
This combination of imaging findings is distinctive for MD 
and is rarely present in other vertigo related entities. This 
can be particularly helpful in patients with atypical presen-
tations of MD: endolymphatic hydrops and increased peri-
lymphatic enhancement were found in 43% of patients of 
probable MD group; this can have great impact on treatment 
strategies for these patients although longitudinal research 
is needed to confirm clinical progression to definite MD.
For daily routine, we propose a systematic approach to 
conventional and endolymphatic hydrops imaging findings 
(Table 3). We would like to emphasize the importance of 
the correlation between clinical and radiological findings 
on patient management.
Qualitative versus/(semi‑) quantitative 
image evaluation
The magnetic resonance technique of endolymphatic 
hydrops is based on volumetric sequences (T2 3D and T2 
3D FLAIR) (Fig. 4), allowing multiplanar and three-dimen-
sional reformatting and measurements of the structures.
The qualitative/semi quantitative evaluation method uses 
different planes to evaluate the vestibule and the cochlea. 
Vestibule evaluation is classically described according to 
the plane of the lateral semicircular canal, using the lowest 
axial image at the inferior part of the vestibule. According 
to previous histological and imaging studies [58], the sac-
cule occupies the most anterior, inferior, and medial part 
of the vestibule. Evaluating hydrops in the highest axial 
images through the vestibule can result in false positive 
diagnosis of vestibular hydrops. Cochlea evaluation is clas-
sically described according the axial plane along the greater 
axis of cochlear modiolus. The qualitative/semi quantita-
tive method consists of a manual selection of areas of the 
vestibular endolymphatic space and its total area, thus esti-
mating the ratio between the two, in order to classify the 
hydrops according to the scale adopted [54, 57, 59]. Some 
groups include the ampulla of the lateral semicircular canal 
on the measurements of the total area of the vestibule [12], 
which tends to facilitate the identification of anatomical 
structures; the ampulla inclusion tends to obtain lower ratios 
of endolymphatic space, as only extreme hydrops will pro-
duce herniation of the endolymph outside vestibule. Some 
publications omit the measurement method that was used. 
The evaluation of the cochlear space is more difficult, espe-
cially in the intravenous technique and with fewer channel 
antennas. It uses the axial plane along the greater axis of 
modiolus, also with human judgment factor inherent on the 
Table 2  Classification of endolymphatic space by MRI from Nagoya described by Nakashima (2009) [47] and Barath [54]
EH grade Vestibule Cochlea
Nakashima Barath Nakashima Barath
No EH (grade 0)  ≤ 33%  ≤ 50% No Reissner membrane dislocation No dilated cochlear duct
Light EH (grade 1)  > 33%, ≤ 50%  > 50%, < 100% Reissner membrane dislocation
Cochlear duct ≤ scala vestibuli
Scala vestibuli partially obliterated
Severe EH (grade 2)  > 50% 100% Cochlear duct > scala vestibuli Scala vestibuli totally obliterated
Table 3  Methodology proposed for analysis and reporting conventional and endolymphatic hydrops imaging
MRI sequences Method Purpose
T2-weighted high resolution (isotropic) Multiplanar analysis • Defining the outer margin of the perilymphatic space
• Defining the axial planes for vestibule and cochlea
HYDROPS or delayed T2 FLAIR Gad Multiplanar analysis • Identify saccule and utricle
• Grading vestibular hydrops according lateral semicircular 
canal plane using the lowest slice
• Grading cochlear hydrops according midmodiolar plane and 
using the maximum grade
Delayed T2 FLAIR Gad Signal intensity analysis • Look for asymmetric perilymphatic enhancement of endo-
lymphatic structures (mainly basal turn of the cochlea)
T1-weighted high-resolution pre and 
post-gad (IAC)
T2-weighted high resolution (IAC)
T2 Flair and diffusion (brain)
Evaluation of morphology and signal 
of inner ear, cisterns, and brain 
structures






evaluation and with a lower rate of interobserver agreement. 
However, even with these drawbacks, interobserver agree-
ment in the assessment of MRI of the cochlea and vestibule 
according Barath’s scale [54] has proved to be higher than 
interobserver agreement in the clinical evaluation accord-
ing to the current criteria for diagnosing MD [57]. Overall, 
we think radiologist expertise may play a crucial role on 
these high intra and inter observer agreement on imaging 
evaluation.
Adding to this, the evaluation of the enhancement of the 
perilymphatic enhancement has recently shown to be crucial 
on imaging evaluation of MD [57, 58] (Figs. 11 and 12). It 
consists on evaluation of signal intensity of basal turn of 
the cochlea and can be qualitative (visual inspection—peri-
lymphatic enhancement asymmetry) or quantitative (signal 
intensity ratio of cochlear signal taking as a reference the 
signal intensity of brain structures such as middle cerebel-
lar peduncle [58], cerebellar hemispheres [60], or medulla 
oblongata [61]). It might also serve as a marker of the degree 
of blood/perilymphatic barrier breakdown in some patients, 
a useful tool to follow-up patients with suspected or con-
firmed MD (Fig. 12).
Despite the high interobserver agreement on these semi-
quantitative techniques, the volume measurement of three-
dimensional structures is more objective, and can be auto-
mated [62, 63], but it needs good quality images, usually 
obtained with intratympanic technique. The volumetry may 
have an interesting role in the longitudinal assessment of 
patients and in monitoring the effect of therapies. Gurkov 
proposes a method of measuring volumes based on the com-
bination of two sequences (T2 3D SPACE and T2 3D IR 
with intratympanic injection of gadolinium) and automated 
assessments of the total and relative volume between the dif-
ferent spaces [62]. In MD, Gurkov finds an average percent-
age value for the endolymphatic space of 15% in the cochlea 
and 28% in the vestibule.
The volume measurement technique was applied by a 
Japanese group [63] to 24 patients with chronic rhinosi-
nusitis, without audiovestibular symptoms, with some 
additional data being obtained from a population theoreti-
cally without pathology. A recent study [64] made, for the 
first time, a semiautomatic volumetric assessment with 3 T 
MRI using intravenous technique, quantifying the volume of 
endolymphatic spaces and total membranous labyrinths in 
a population of 98 patients with MD disease and 47 healthy 
volunteers. This data, scarce in the literature, is of crucial 
importance, since it allows characterizing the “normal pat-
tern” of the endolymphatic space in the absence of pathol-
ogy. Healthy individuals were selected according to a ques-
tionnaire, with no history of hearing loss, vertigo, diseases 
of the middle or inner ear, cranial disease, cranial trauma, 
kidney disease, heart disease, medications, or gadolinium 
allergy. Unfortunately, the evaluation of the control group 
did not include audiometric (or vestibular) evaluation. They 
found percentages of endolymphatic hydrops of 13.9 + / − 7.9 
in the group of healthy volunteers and values significantly 
higher in symptomatic ears in MD disease, 24.1% for the 
cochlea and 37.5% for the vestibule, with the later findings 
consistent with those found by Gurkov [62]. This study is 
extremely important, although difficult to reproduce given 
the necessity of administration of contrast to individuals 
with no clinical indication for this. We must point out the 
absence of audiometric documentation of healthy individu-
als, which would have given an even greater credibility to 
MRI in MD.
Manual volumetric assessment takes a long time [65], 
despite being faster with semi-automated assessments [62]; 
this difference in the time of image evaluation is consid-
ered statistically significant in the study by Homann (2 min 
versus 14 min) and the authors conclude that in daily clini-
cal practice semi-quantitative evaluation is sufficient, using 
manual volumetry (cut to cut) in doubtful cases or following 
patients. However, they consider that in terms of the final 
result, volumetry is more accurate, especially if a semi-auto-
matic method is available in the evaluation [62], in order to 
streamline the process and save time.
Future perspectives of MRI
It seems evident that MRI demonstration of endolymphatic 
hydrops has a significant correlation with clinical and physi-
ological parameters and with the clinical course of the dis-
ease [9, 58, 65–67]. There is however a relative lack of data 
regarding healthy ears. Many studies consider the asymp-
tomatic ear as the “normal” one but we know MD tends to 
be a bilateral process and endolymphatic hydrops can be 
identified in the pre-symptomatic phase of the disease, so 
it is crucial to characterize the membranous labyrinth in 
healthy individuals with documented normal audiograms 
and establish normal patters in the healthy population, in 
order to serve as a comparison with inner ear disorders. We 
suggest studying patients who need contrast MRI of other 
anatomical regions, without audiovestibular symptoms and 
with normal audiogram, for example, patients with failed 
back surgery (disc herniation).
We know that MD is a chronic condition but the natural 
history of the disease is not well elucidated and longitudi-
nal studies regarding evolution of endolymphatic spaces in 
MD are scarse [68–71]. Although the scientific evidence 
is poor, it seems some patients have progression of endo-
lymphatic hydrops in the course of MD (Fig. 13). Besides 
that, there are still few controlled clinical studies on the 
effectiveness of different treatments in MD and there is 
currently no treatment with proven benefit. No benefit was 
seen on endolymphatic hydrops in patients under medical 
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treatment [68, 70], although factors as insufficient dosage, 
insufficient MRI resolution, and short follow-up period 
have been implicated. These findings are not supported 
by a longitudinal study with acetazolamide therapy [70] 
(5 patients) that points to a clinical and imaging improve-
ment in majority of patients, with one clinical and imag-
ing recurrence with treatment interruption. Surgical endo-
lymphatic sac decompression (7 patients) seems to result 
in clinical and imaging improvement in a 2-year follow-
up study. The ideal treatment for MD should reverse the 
progression of endolymphatic hydrops, the pathological 
substrate of the disease. Volumetric evaluation of the 
endolymphatic space [62] may play a central role as a 
biomarker for response in MD as it permits quantitative 
assessment of the effect of distinct therapeutic strategies 
on endolymphatic hydrops.
Conclusion
MD diagnostic criteria remain clinical although endolym-
phatic hydrops imaging seems more reproducible than clini-
cal evaluation. Despite the longstanding recognition of endo-
lymphatic hydrops as a central pathophysiological factor of 
the disease and scientific evidence of a correlation between 
endolymphatic hydrops and clinical parameters, MRI iden-
tification of endolymphatic hydrops is currently not consid-
ered in the diagnosis of the disease and this is particularly 
relevant in management of monosymptomatic, incomplete 
phenotypes, and bilateral clinical presentations of MD.
Improvement of MRI technique, recognition of imaging 
pitfalls, and keeping regular clinical feedback is important. 
Different study protocols should be adjusted to each MRI 
scanner, according to their specificities, and it is important 
that each center establishes the standard of normality for 
the applied technique; obtaining data for healthy individu-
als is, however, hampered by ethical issues related to the 
administration of contrast in healthy individuals. Volumet-
ric assessment of endolymphatic spaces may be helpful in 
assessment of the efficacy of different treatment strategies.
Longitudinal hydrops studies are particularly scarce and 
those can bring some light to the pathophysiology of MD.
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